Another partnership has been formed in the autonomous vehicle world. SAE, Ford, GM, and Toyota have announced the formation of the Autonomous Vehicle Safety Consortium (AVSC).

The focus of AVSC is to work to safely advance testing, pre-competitive development, and deployment of SAE Level 4 and 5 automated vehicles. It is the goal of the

Today, The Wall Street Journal published a special section on artificial intelligence with multiple articles on its impact on various industries, new applications of the technology, and its general impact on corporate management. This link to an article on the latter topic is worthwhile, as are the other articles in today’s edition of the

In a recent lawsuit filed in the Northern District of California, Tesla alleged that a former employee, Guangzhi Cao, copied more than 300,000 files of Tesla’s Auto-pilot related source code before leaving to work for one of Tesla’s competitors, Xiaopeng Motors Technology Company Ltd.

This lawsuit highlights the difficulties associated with potential collaboration in

A new federal council has been created that may help bridge the gap between the federal government and the current state of autonomous vehicle laws and regulations being adopted by cities and states across the country. The Secretary of the U.S. Department of Transportation (USDOT), Elaine Chao, announced yesterday at the South by Southwest Conference

Today, March 4, 2019, Pittsburgh’s Mayor Bill Peduto signed an executive order outlining the objectives and expectations from the city for testing autonomous vehicles. Transparency and reporting are two of the city’s biggest priorities set forth in the order.

The Department of Mobility and Infrastructure (DOMI) will be in charge of the oversight of autonomous

FDA continues to be active in emphasizing the importance of artificial intelligence in health care. Now, FDA has committed to a program of creating a knowledgeable, sustainable, and agile data science workforce ready to review and approve devices based on artificial intelligence.

In April of last year, FDA Commissioner Scott Gottlieb, in discussing the